
Danaher Corporation DHR
€ 178.57
0.53%
Danaher Corporation ROE | DHR
ROE Jährlich Danaher Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6.88 | 7.87 | 8.91 | 14.39 | 14.24 | 9.17 | 9.93 | 9.39 | 9.45 | 11.07 | 14.13 | 11.08 | 12.0 | 12.54 | 12.8 |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 14.39 | 6.88 | 10.92 |
ROE Vierteljährlich Danaher Corporation
| 2025-Q1 | 2024-Q4 | 2024-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5.95 | 5.64 | 9.25 | 10.93 | 9.99 | 12.66 | 13.23 | 10.61 | 12.83 | 12.38 | 10.54 | 6.05 | 10.2 | 10.18 | 10.27 | 9.87 | 8.37 | 8.52 | 8.49 | 9.4 | 10.0 | 9.82 | 9.54 | 9.45 | 9.45 | 8.98 | 9.72 | 11.1 | 10.76 | 14.98 | 15.06 | 14.17 | 14.1 | 11.08 | 11.04 | 11.11 | 11.81 | 11.57 | 11.43 | 12.04 | 11.83 | 12.05 | 12.45 | 12.58 | 12.64 | 12.85 | 13.53 | 12.85 | 3.1 | 3.84 | 2.54 |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 15.06 | 2.54 | 10.45 |
ROE anderer Aktien in der Diagnostik & Forschung
| Name | ROE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Enzo Biochem
ENZ
|
-46.47 | - | -8.98 % | $ 14.8 K | ||
|
QIAGEN N.V.
QGEN
|
11.25 | - | - | $ 10.6 B | ||
|
Centogene N.V.
CNTG
|
140.54 | - | -6.23 % | $ 30.6 M | ||
|
Charles River Laboratories International
CRL
|
-4.56 | $ 288.5 | 0.54 % | $ 14.3 B | ||
|
Aspira Women's Health
AWH
|
0.18 | - | -6.19 % | $ 10.5 M | ||
|
DarioHealth Corp.
DRIO
|
-61.41 | $ 7.24 | 3.72 % | $ 28.8 M | ||
|
Brainsway Ltd.
BWAY
|
4.69 | $ 14.15 | 1.61 % | $ 481 M | ||
|
Celcuity
CELC
|
-176.06 | $ 95.7 | 0.44 % | $ 4.47 B | ||
|
Oxford Immunotec Global PLC
OXFD
|
-0.85 | - | - | $ 562 M | ||
|
Check-Cap Ltd.
CHEK
|
120.45 | - | - | $ 9.42 M | ||
|
Akumin
AKU
|
325.23 | - | -17.87 % | $ 25.9 M | ||
|
Accelerate Diagnostics
AXDX
|
89.3 | - | -61.36 % | $ 2.46 M | ||
|
Biocept
BIOC
|
-362.16 | - | -13.05 % | $ 7.29 M | ||
|
Global Cord Blood Corporation
CO
|
10.27 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-38.13 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-656.53 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-147.83 | - | 0.12 % | $ 80.1 M | ||
|
Chembio Diagnostics
CEMI
|
-130.86 | - | 0.22 % | $ 16.8 M | ||
|
PRA Health Sciences, Inc.
PRAH
|
13.32 | - | - | $ 10.7 B | ||
|
DermTech
DMTK
|
-176.45 | - | -11.32 % | $ 2.94 M | ||
|
Quest Diagnostics Incorporated
DGX
|
13.84 | $ 237.14 | 2.07 % | $ 26.3 B | ||
|
DexCom
DXCM
|
30.46 | $ 87.9 | 0.02 % | $ 34.3 B | ||
|
Heska Corporation
HSKA
|
-4.71 | - | - | $ 1.31 B | ||
|
HTG Molecular Diagnostics
HTGM
|
-400.51 | - | -20.0 % | $ 1.06 M | ||
|
ICON Public Limited Company
ICLR
|
2.49 | $ 164.85 | 0.78 % | $ 12.9 B | ||
|
Soleno Therapeutics
SLNO
|
4.64 | - | - | $ 2.69 B | ||
|
Psychemedics Corporation
PMD
|
-36.28 | - | -1.84 % | $ 15.3 M | ||
|
Motus GI Holdings
MOTS
|
-478.86 | - | -34.28 % | $ 263 K | ||
|
Syneos Health
SYNH
|
7.63 | - | - | $ 4.46 B | ||
|
Laboratory Corporation of America Holdings
LH
|
10.17 | $ 326.89 | 0.29 % | $ 27.2 B | ||
|
Invitae Corporation
NVTA
|
-98.02 | - | - | $ 21.2 M | ||
|
Organovo Holdings
ONVO
|
1259.6 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
74.14 | - | -16.95 % | $ 1.54 M | ||
|
T2 Biosystems
TTOO
|
178.62 | - | -39.35 % | $ 313 K | ||
|
Anixa Biosciences
ANIX
|
-72.07 | $ 3.07 | 0.66 % | $ 99.6 K | ||
|
PerkinElmer
PKI
|
3.33 | - | -0.91 % | $ 14.7 B | ||
|
Meridian Bioscience
VIVO
|
11.54 | - | - | $ 1.49 B | ||
|
Quotient Limited
QTNT
|
86.84 | - | -11.32 % | $ 1.1 M | ||
|
Mettler-Toledo International
MTD
|
-3677.41 | $ 1 345.26 | 0.11 % | $ 27.7 B | ||
|
Myriad Genetics
MYGN
|
-99.46 | $ 3.18 | 1.57 % | $ 294 M | ||
|
ENDRA Life Sciences
NDRA
|
-310.93 | $ 6.05 | 6.51 % | $ 4.76 M | ||
|
National Research Corporation
NRC
|
82.92 | $ 21.53 | 1.32 % | $ 482 M | ||
|
Renalytix AI plc
RNLX
|
425.97 | - | 5.66 % | $ 22.7 M | ||
|
Interpace Biosciences
IDXG
|
109.89 | $ 1.45 | 2.11 % | $ 6.41 M | ||
|
OPKO Health
OPK
|
-17798.68 | $ 1.64 | 1.86 % | $ 1.23 B | ||
|
Pacific Biosciences of California
PACB
|
-10214.99 | $ 1.35 | 3.85 % | $ 405 M | ||
|
IQVIA Holdings
IQV
|
20.91 | $ 267.77 | 2.95 % | $ 46 B | ||
|
Surmodics
SRDX
|
-9.71 | - | - | $ 608 M | ||
|
Personalis
PSNL
|
-31.12 | $ 17.2 | 2.2 % | $ 1.53 B | ||
|
Quidel Corporation
QDEL
|
60.8 | $ 13.97 | 0.29 % | $ 588 M |